Semaglutide was dosed for the full period, while antibody dosing with the -MSTN and -ActA antibodies was started in Week 2 as an add-on to semaglutide and dosed through Week 12 (and was presumed to have more durable actions due to the extended half-life of the antibodies)
However, several recent findings are different from the previous results
BPC-157 (Body Protection Compound-157) is a synthetic peptide fragment originally derived from a protective protein found in gastric juice and has been studied in preclinical models for effects on tendon, ligament, muscle, nerve, and gastrointestinal tissue integrity
Step therapy documentation
Phase 2 trial results showed even better results for retatrutide
Your test results will come back clean, with no mention of your prescription